Search Press releases Keywords From To 25 Jun 2021 Disposals of own shares Read More 25 Jun 2021 UCB Receives Positive CHMP Opinion Recommending Approval of BIMZELX[®*] (bimekizumab) in the EU for the Treatment of Adults with Moderate to Severe Plaque Psoriasis Read More 18 Jun 2021 Disposals of own shares Read More 11 Jun 2021 Disposals of own shares Read More 4 Jun 2021 Disposals of own shares Read More 1 Jun 2021 EULAR 2021: New Data from UCB’s Rheumatology Portfolio Demonstrates Real World Value for Patients with axSpA, PsA, and Women of Childbearing Age Read More Pagination First page Previous page Previous … Page 40 Page 41 Page 42 Page 43 Current page 44 Page 45 Page 46 Page 47 Page 48 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
